Skip to content
The Policy VaultThe Policy Vault

adalimumab-adbm — Medica

All Conditions (see standard Inflammatory Conditions – Adalimumab Products PA Policy)

Preferred products

  • adalimumab-adaz
  • adalimumab-adbm
  • Simlandi
  • adalimumab-ryvk

Initial criteria

  • Patient meets the standard Inflammatory Conditions – Adalimumab Products Prior Authorization Policy criteria.

Reauthorization criteria

  • Patient continues therapy and meets the standard Inflammatory Conditions – Adalimumab Products Prior Authorization Policy criteria.

Approval duration

1 year